Debra(Berger)SarasohnMD

PubMed

• A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2).
  Melissa Lumish, M Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth Cohen, Claire Friedman, Rachel Grisham, Jason Konner, Chrisann Kyi, Maria Rubinstein, Tif...> ;Gynecologic Oncology. 2024 Mar 1
• Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer.
  Clarissa Lam, Debra Sarasohn, Britta Weigelt, Dmitriy Zamarin> ;Gynecologic Oncology Reports. 2023 Oct 1
• 4 citations
  Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Rem...
  Beryl L Manning-Geist, Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H Kim, Debra Sarasohn, Krysten Soldan, William P Tew, Nicholas J Sarlis, Dmitriy Zamarin, S...> ;Cancers. 2023 Feb 25
• 4 citations
  Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study.
  Maria M Rubinstein, Eric Rios Doria, Jason Konner, Stuart Lichtman, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Tiffany Troso-Sandoval, Claire Friedman, Roisin O'Cearbha...> ;Gynecologic Oncology. 2023 Feb 1
• 4 citations
  Waxing and waning pattern of mTOR inhibitor-associated pneumonitis in renal cell carcinoma patients: A retrospective observational study.
  Jill Gluskin, Andrew J. Plodkowski, Jeffrey Girshman, Debra M. Sarasohn, Ainhoa Viteri-Jusué, Sumar Hayan, Jean Torrisi> ;Clinical Imaging. 2021 Mar 1
• 21 citations
  A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kette...
  Alli M. Straubhar, Olga T. Filippova, Renee A. Cowan, Yulia Lakhman, Debra M. Sarasohn, Ines Nikolovski, Jean Torrisi, Weining Ma, Nadeem R. Abu-Rustum, Ginger J. Gard...> ;Gynecologic Oncology. 2020 Jun 6
• 2 citations
  A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
  Karen Cadoo, Rachel N. Grisham, Roisin E. O'Cearbhaill, Nicole N. Boucicaut, Melissa Henson, Alexia Iasonos, Qin Zhou, Debra M. Sarasohn, Jacqueline Gallagher, Sara Kr...> ;Gynecologic Oncology. 2020 Apr 1
• 46 citations
  Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia.
  Gerald A. Soff, Yimei Miao, Gemma Bendheim, Jeanette Batista, Jodi V. Mones, Rekha Parameswaran, Cy Wilkins, Sean M. Devlin, Ghassan K. Abou-Alfa, Andrea Cercek, Nancy...> ;Journal of Clinical Oncology. 2016 May 20
• 21 citations
  Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience.
  Gerald A. Soff, Jodi V. Mones, Cy Wilkins, Sean M. Devlin, Eva Haegler-Laube, Jonathan Wills, Debra M. Sarasohn, Krishna Juluru, Michael E Singer, Yimei Miao, Jeanette...> ;Research and Practice in Thrombosis and Haemostasis. 2019 May 24
• 15 citations
  Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease.
  Amanika Kumar, Shannon P. Sheedy, Bohyun Kim, Rudy S. Suidan, Debra M. Sarasohn, Ines Nikolovski, Yulia Lakhman, Michaela E. McGree, Amy L. Weaver, Dennis S. Chi, Will...> ;Gynecologic Oncology. 2019 Jul 1
• 11 citations
  Causes of Avascular Hypoechoic Testicular Lesions Detected at Scrotal Ultrasound: Can They Be Considered Benign?
  Weining Ma, Debra M. Sarasohn, Junting Zheng, Hebert Alberto Vargas, Ariadne M. Bach> ;AJR. American Journal of Roentgenology. 2017 Jun 22
• 83 citations
  A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithel...
  Rudy S. Suidan, Debra M. Sarasohn, Jerrold B. Teitcher, Revathy B. Iyer, Qin Zhou, Alexia Iasonos, J. Denesopolis, Oliver Zivanovic, Kara Long Roche, Yukio Sonoda, Rob...> ;Gynecologic Oncology. 2017 Apr 1
• 77 citations
  Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study
  Simon Mantha, Eva S. Laube, Yimei Miao, Debra M. Sarasohn, Rekha Parameswaran, Samantha Stefanik, Gagandeep Brar, Patrick Samedy, Jonathan Wills, Stephen Harnicar, Ger...> ;Journal of Thrombosis and Thrombolysis. 2017 Feb 1
• 39 citations
  Is It Time to Centralize Ovarian Cancer Care in the United States
  Renee A. Cowan, Roisin E. O'Cearbhaill, Ginger J. Gardner, Douglas A. Levine, Kara Long Roche, Yukio Sonoda, Oliver Zivanovic, William P. Tew, Evis Sala, Yulia Lakhman...> ;Annals of Surgical Oncology. 2016 Mar 1
• 13 citations
  Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance.
  Simon Mantha, Debra M. Sarasohn, Weining Ma, Sean M. Devlin, Dennis S. Chi, Kara Long Roche, Rudy S. Suidan, Kaitlin M. Woo, Gerald A. Soff> ;American Journal of Obstetrics and Gynecology. 2015 Aug 1
• 151 citations
  A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulki...
  , , , , , , , , , , , , , , , , > ;Gynecologic Oncology. 2014 Sep 1
• 60 citations
  Stage IB1 Cervical Cancer: Role of Preoperative MR Imaging in Selection of Patients for Fertility-Sparing Radical Trachelectomy
  Yulia Lakhman, Oguz Akin, Kay J. Park, Debra M. Sarasohn, Junting Zheng, Debra A. Goldman, Michael J. Sohn, Chaya S. Moskowitz, Yukio Sonoda, Hedvig Hricak, Nadeem R. ...> ;Radiology. 2013 Oct 1
• 18 citations
  Phase I Trial of Weekly and Twice-Weekly Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Relapsed or Refractory Non–Hodgkin Lymphoma
  John F. Gerecitano, Carol S. Portlock, Paul A. Hamlin, Craig H. Moskowitz, Ariela Noy, David J. Straus, Philip Schulman, Otilia Dumitrescu, Debra M. Sarasohn, Jennifer...> ;Clinical Cancer Research. 2011 Apr 15
• 43 citations
  Implementation of evidence-based guidelines for thyroid nodule biopsy: a model for establishment of practice standards.
  Niamh M. Hambly, Mithat Gonen, Scott R. Gerst, Duan Li, Xiaoyu Jia, Svetlana Mironov, Debra M. Sarasohn, Stephen E. Fleming, Lucy E. Hann> ;AJR. American Journal of Roentgenology. 2011 Mar 1
• 12 citations
  Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritone...
  Dennis S. Chi, Joyce N. Barlin, Charles F Levenback, Svetlana Mironov, Debra M. Sarasohn, Revathy B. Iyer, Fanny Dao, Hedvig Hricak, Richard R. Barakat> ;International Journal of Gynecological Cancer. 2010 Apr 1
• 37 citations
  Time to Treatment Response in Patients with Follicular Lymphoma Treated with Bortezomib Is Longer Compared with Other Histologic Subtypes
  Owen A. O'Connor, Carol S. Portlock, Craig H. Moskowitz, Paul A. Hamlin, David J. Straus, John F. Gerecitano, Mithat Gonen, Otilia Dumitrescu, Debra M. Sarasohn, John ...> ;Clinical Cancer Research. 2010 Jan 15
• 128 citations
  Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refrac...
  Owen A. O'Connor, Steven M. Horwitz, Paul A. Hamlin, Carol S. Portlock, Craig H. Moskowitz, Debra M. Sarasohn, Ellen Neylon, Jill Mastrella, Rachel Hamelers, Barbara M...> ;Journal of Clinical Oncology. 2009 Sep 10
• 43 citations
  Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma.
  John F. Gerecitano, Carol S. Portlock, Craig H. Moskowitz, Paul A. Hamlin, David J. Straus, Andrew D. Zelenetz, Zhigang Zhang, Otilia Dumitrescu, Debra M. Sarasohn, Do...> ;British Journal of Haematology. 2009 Sep 1
• 61 citations
  Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed...
  Owen A. O'Connor, Craig H. Moskowitz, Carol S. Portlock, Paul A. Hamlin, David J. Straus, Otilia Dumitrescu, Debra M. Sarasohn, Mithat Gonen, John Butos, Ellen Neylon,...> ;British Journal of Haematology. 2009 Apr 1
• 67 citations
  Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chem...
  Owen A. O'Connor, Paul A. Hamlin, Carol S. Portlock, Craig H. Moskowitz, Ariela Noy, David J. Straus, Barbara MacGregor-Cortelli, Ellen Neylon, Debra M. Sarasohn, Otil...> ;British Journal of Haematology. 2007 Nov 1
• Join now to see all

Lectures

• Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018